What is the primary objective of GMP?

The primary objective of GMP is to ensure products are consistently produced and controlled to meet their predetermined quality standards, preventing contamination, mix-ups, mislabeling, and variability. This preventive system—spanning people, premises, processes, procedures, and products—relies on validated processes, independent quality oversight, and documentation rather than end-product testing alone, as codified in FDA 21 CFR Parts 210/211 and EU EudraLex Volume 4.

Who is legally or professionally required to comply with GMP?

GMP compliance is legally required for manufacturers of pharmaceuticals, biologics, APIs, and related products under FDA 21 CFR Parts 210/211, EU EudraLex Volume 4, and WHO GMP. This includes contract manufacturers (CMOs), API producers (ICH Q7), and sterile product facilities (EU Annex 1), with the Quality Control Unit (§211.22) or Qualified Person (Annex 16) holding release authority; non-compliance affects market access globally via PIC/S and MRAs.

Does GMP require an external audit or third-party certification?

GMP does not mandate third-party certification but requires regular regulatory inspections by authorities like FDA, EMA, or national agencies. Internal audits and self-inspections are compulsory (EU Chapter 1, FDA §211.22), with external audits for suppliers; WHO GMP and PIC/S facilitate mutual recognition, but enforcement relies on unannounced inspections assessing state of control via quality data and CAPA trends.

How often should an assessment for GMP be performed?

GMP assessments must be performed annually through Product Quality Reviews (PQR) per FDA §211.180(e) and ICH Q7, with risk-based internal audits and self-inspections at least yearly. Continuous monitoring via CAPA, change control, and management review (ICH Q10) is required, plus requalification post-maintenance or changes; EU Annex updates (e.g., Annex 1 since 25 Aug 2024) trigger reassessments.

What are the consequences of non-compliance with GMP?

Non-compliance with GMP results in regulatory actions including Form 483 observations, Warning Letters, import alerts, product seizures, fines up to $50k/day (FDA), and manufacturing halts. Severe cases lead to consent decrees, recalls (as in 1937 Elixir Sulfanilamide), market exclusion via MRAs, and criminal liability; remediation costs millions, eroding licensure and revenue.

Can GMP be mapped to other international frameworks?

Yes, GMP maps closely to ICH Q7 (APIs), ICH Q9 (QRM), and ICH Q10 (PQS), with PIC/S enabling inspector harmonization. FDA 21 CFR 211 aligns with EU GMP chapters on personnel (Ch. 2), premises (Ch. 3), and documentation (Ch. 4); WHO GMP provides baseline proportionality, facilitating global compliance without independent mention of other standards.

What is the first step to begin implementing GMP?

The first step to implement GMP is conducting a comprehensive gap analysis against regulatory requirements like 21 CFR Part 211 or EudraLex Volume 4. This identifies deficiencies in the 5 Ps (People, Premises, Processes, Procedures, Products), informs a Validation Master Plan (VMP), and prioritizes remediation via QRM, establishing executive sponsorship and resource allocation.

What is the primary objective of BREEAM?

BREEAM's primary objective is to provide a science-based sustainability assessment and certification framework for the built environment, measuring performance across the asset lifecycle. It converts sustainability ambitions into measurable credits across ten core categories—Management, Health & Wellbeing, Energy, Transport, Water, Materials, Waste, Land Use & Ecology, Pollution, and Innovation—yielding ratings from Pass (≥30%) to Outstanding (≥85%) via weighted scoring and third-party verification.

Who is legally or professionally required to comply with BREEAM?

No organizations are legally required to comply with BREEAM, as it is a voluntary certification scheme. Professionally, it applies to developers, owners, and operators of buildings, infrastructure, communities, and fit-outs seeking market differentiation, ESG credibility, planning incentives, or alignment with investor demands in jurisdictions with local adaptations via National Scheme Operators in Austria, Germany, Netherlands, Norway, Spain, and Sweden.

Does BREEAM require an external audit or third-party certification?

Yes, BREEAM mandates third-party certification through licensed BREEAM Assessors and BRE Global quality audits. Assessors compile evidence against scheme-specific technical manuals and submit for BRE verification under ISO/IEC 17065 accreditation, ensuring impartiality via sampling, site visits, and compliance with Knowledge Base Compliance Notes (KBCNs).

How often should an assessment for BREEAM be performed?

BREEAM New Construction assessments occur once per project at design and post-construction stages, while BREEAM In-Use certifications require reassessment every 3 years. Ongoing monitoring via post-occupancy evaluation (POE) and sub-metering supports continuous improvement, with scheme updates like Version 7 necessitating periodic reviews of KBCNs for compliance.

What are the consequences of non-compliance with BREEAM?

Non-compliance with BREEAM results in denied credits, lower ratings, or failed certification, with no direct legal penalties as it is voluntary. Indirect consequences include lost market premiums (up to 25-30% rental uplifts), planning delays, investor scrutiny, and ESG reporting gaps, particularly for EU Taxonomy alignment in Version 7.

Can BREEAM be mapped to other international frameworks?

BREEAM is not formally mapped to other frameworks in its core requirements and must stand alone for certification. However, Version 7 enhances alignment with policy drivers like the EU Taxonomy through whole-life carbon, net-zero strategies, biodiversity, and resilience emphases, supporting broader ESG disclosures without cross-standard credit substitution.

What is the first step to begin implementing BREEAM?

The first step is to select the appropriate scheme (e.g., New Construction, In-Use) and version, then appoint a licensed BREEAM Assessor early at project inception. This enables pre-assessment, credit targeting, and integration into design, procurement, and governance per technical manuals and KBCNs.

Standards Comparison

GMP vs BREEAM

GMP

Mandatory

1963

Regulatory standards for pharmaceutical manufacturing quality control

BREEAM

Voluntary

1990

Global certification framework for sustainable built environment performance

Quick Verdict

GMP ensures pharmaceutical manufacturing quality and safety through mandatory regulations, while BREEAM certifies sustainable buildings voluntarily. Companies adopt GMP for legal compliance and patient protection; BREEAM for ESG value, energy savings, and market differentiation.

Manufacturing Quality

GMP

Good Manufacturing Practice (GMP) regulations

Cost

€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Independent quality unit approves/rejects batches
Risk-based Quality Risk Management (QRM) integration
Validated processes and qualified equipment required
Comprehensive documentation with ALCOA+ data integrity
Continual improvement via CAPA and audits

Building Sustainability

BREEAM

Building Research Establishment Environmental Assessment Method

Cost

€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Credit-based scoring with category weightings
Third-party BRE certification and audits
Lifecycle schemes for new, existing, infrastructure
10 core sustainability assessment categories
Knowledge Base updates and KBCNs

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

GMP Details

What It Is

Good Manufacturing Practice (GMP), including cGMP (21 CFR Parts 210/211), EU GMP (EudraLex Volume 4), and WHO GMP, is a regulatory framework enforcing minimum standards for manufacturing pharmaceuticals, biologics, and related products. Its primary purpose is preventing contamination, mix-ups, and variability through preventive controls across people, premises, processes, and documentation. It employs a risk-based approach via Quality Risk Management (QRM) and lifecycle systems like ICH Q10 Pharmaceutical Quality System (PQS).

Key Components

**5 Ps pillarsPeople, Products, Procedures, Processes, Premises.
Core elements: independent Quality Control Unit, validated processes/equipment, ALCOA+ documentation, CAPA, change control, supplier oversight.
Built on ICH Q9 (QRM) and regional codes; no fixed control count, but comprehensive subparts/annexes.
Compliance via inspections, no central certification but site approvals.

Why Organizations Use It

Mandated for market access, GMP reduces recalls, liabilities, and enforcement (warnings, seizures). It ensures patient safety, supply reliability, and operational efficiency, building regulator and stakeholder trust.

Implementation Overview

Phased: gap analysis, Validation Master Plan (VMP), training, qualification (IQ/OQ/PQ), audits. Applies to pharma/biologics firms globally; requires ongoing inspections, audits.

BREEAM Details

What It Is

BREEAM (Building Research Establishment Environmental Assessment Method) is a science-led sustainability certification framework for the built environment. Launched in 1990 by BRE, it assesses environmental, social, and resilience performance across buildings, infrastructure, and communities. Its credit-based methodology evaluates performance via weighted categories, yielding ratings from Pass to Outstanding.

Key Components

**10 core categoriesManagement, Health & Wellbeing, Energy, Transport, Water, Materials, Waste, Land Use & Ecology, Pollution, Innovation.
Hundreds of credits with prerequisites, evidence requirements, and weightings.
Built on third-party assurance via licensed assessors and BRE audits (ISO/IEC 17065 accredited).
Schemes for lifecycle stages: New Construction, In-Use, Refurbishment, Infrastructure.

Why Organizations Use It

Drives ESG alignment, net-zero strategies, and value uplift (8-12% premiums).
Mitigates regulatory risks (e.g., EU Taxonomy) and enhances marketability.
Improves operational efficiency, occupant health, and resilience.
Builds investor trust through audited benchmarks.

Implementation Overview

Phased approach: pre-assessment, design integration, construction evidence, certification.
Early assessor appointment essential; applies globally with local adaptations.
BRE-led audits; In-Use recertification every 3 years.

Key Differences

Aspect	GMP	BREEAM
Scope	Manufacturing processes, quality controls, facilities	Building sustainability, energy, health, ecology
Industry	Pharma, biologics, food, cosmetics globally	Construction, real estate, infrastructure worldwide
Nature	Mandatory regulatory framework with inspections	Voluntary third-party certification scheme
Testing	Process validation, audits, batch release testing	Assessor-led evidence review, BRE quality audits
Penalties	Warning letters, recalls, shutdowns, fines	No certification, lost market value, no legal fines

Scope

GMP

Manufacturing processes, quality controls, facilities

BREEAM

Building sustainability, energy, health, ecology

Industry

GMP

Pharma, biologics, food, cosmetics globally

BREEAM

Construction, real estate, infrastructure worldwide

Nature

GMP

Mandatory regulatory framework with inspections

BREEAM

Voluntary third-party certification scheme

Testing

GMP

Process validation, audits, batch release testing

BREEAM

Assessor-led evidence review, BRE quality audits

Penalties

GMP

Warning letters, recalls, shutdowns, fines

BREEAM

No certification, lost market value, no legal fines

Frequently Asked Questions

Common questions about GMP and BREEAM

GMP FAQ

BREEAM FAQ

You Might also be Interested in These Articles...

CIS Controls v8.1 IG1 Ransomware-Resilience Sprint: A 30-60-90 Day Action Plan (With Evidence Checklist)

Tactical CIS Controls v8.1 IG1 playbook for ransomware resilience. 30-60-90 day sprint with tool-agnostic tasks, ownership & evidence checklists to prove progre

From SOC to AI-Native CDC: Redefining Triage and Response in 2026

Explore the shift from SOCs to AI-Native CDCs. Autonomous agents handle Tier 1 triage in 2026, empowering analysts for complex threats. Discover the future of c

You Guide on how to Start Implementing NIS2 in Your Organization

Master NIS2 implementation with our detailed guide. Learn requirements, risk assessment, supply chain security, and compliance steps for your organization. Star

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how GMP and BREEAM compare against other standards

Other GMP Comparisons

Other BREEAM Comparisons

What It Is

Key Components

**5 Ps pillarsPeople, Products, Procedures, Processes, Premises.

Core elements: independent Quality Control Unit, validated processes/equipment, ALCOA+ documentation, CAPA, change control, supplier oversight.

Built on ICH Q9 (QRM) and regional codes; no fixed control count, but comprehensive subparts/annexes.

Compliance via inspections, no central certification but site approvals.

What It Is

Key Components

**10 core categoriesManagement, Health & Wellbeing, Energy, Transport, Water, Materials, Waste, Land Use & Ecology, Pollution, Innovation.

Hundreds of credits with prerequisites, evidence requirements, and weightings.

Built on third-party assurance via licensed assessors and BRE audits (ISO/IEC 17065 accredited).

Schemes for lifecycle stages: New Construction, In-Use, Refurbishment, Infrastructure.

Aspect

GMP

BREEAM

Scope

Manufacturing processes, quality controls, facilities

Building sustainability, energy, health, ecology

Industry

Pharma, biologics, food, cosmetics globally

Construction, real estate, infrastructure worldwide

Nature

Mandatory regulatory framework with inspections

Voluntary third-party certification scheme

Testing

Process validation, audits, batch release testing

Assessor-led evidence review, BRE quality audits

Penalties

Warning letters, recalls, shutdowns, fines

No certification, lost market value, no legal fines